Connect your AI

Doximity DOCS Intangible Purchases

Intangible Purchases at other companies

CorvelCRVL

$8.49M—

Amneal Pharmaceuticals, Inc.AMRX

$7.85M+86.9%

McKessonMCK

$67M-4.3%

GenpactG

$7.52M+1,151%

Other financials

Income statement

Revenue$145.4M+5.1%

Gross profit$126.0M+1.7%

Operating income$24.8M-49.0%

Net income$19.1M-69.4%

EPS (diluted)$0.10-67.7%

Balance sheet

Cash & equivalents$219.2M+4.6%

Total debt$10.2M-17.8%

Total equity$950.8M-12.2%

Total assets$1.1B-11.1%

Cash flow

Operating cash flow$109.5M+11.2%

CapEx-—

Free cash flow$81.6M-17.1%

Valuation

Market cap$3.75B-60.5%

Profitability

Gross margin89.1%-1.1pp

Operating margin33.3%-6.6pp

Net margin30.4%-8.7pp

FCF margin50.6%+2.7pp

Returns & leverage

Return on equity19.3%-3.2pp

Debt / equity0×0.0×

Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Doximity's intangible purchases?: Doximity (DOCS) reported intangible purchases of $15.5K in Q1 2026.
What does intangible purchases mean?: Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.